Regulations are urgently needed to protect children from harm in the unregulated online world, researchers at the University of Otago, New Zealand, say.
MegaPro Medical’s new MRI contrast agent MPB-2043 has completed the first patient admission in Taiwan – Biotech Investments
EQS Newswire / 19/12/2024 / 15:57 UTC+8 A new nanodrug development company – MegaPro Biomedical Co., Ltd. (hereinafter referred to as “MegaPro”,
December 20, 2024